Full enrollment of 195subjects in NORSE THREE achieved in less than one month, significantly ahead of schedule All planned clinical trials for ONS-5010/LYTENAVA™ BLA for wet AMD now fully enrolled or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback